Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1971 Mar 6;104(5):389–393.

Immune Function in Multiple Myeloma

Impaired Responsiveness to Keyhole Limpet Hemocyanin

Jules Harris, Raymond Alexanian, Evan Hersh, Philip Migliore
PMCID: PMC1930886  PMID: 5557914

Abstract

Twenty-three patients with multiple myeloma, four patients with treated localized plasmacytoma and 14 normal subjects were immunized with keyhole limpet hemocyanin (KLH). When compared to the normal subjects, the myeloma patients showed a prolonged induction time for IgM antibody formation, a more rapid switch from IgM to IgG production and a decline in the titre of total antibody produced. In vitro lymphocyte responses to KLH following immunization were reduced in the myeloma group and tended to decline with time in a manner similar to the serum antibody concentration. Most of the myeloma patients tested developed delayed hypersensitivity skin reactions to KLH, but these reactions were smaller than those of the control subjects. The patients with myeloma had also reduced in vitro lymphocyte responses to streptolysin-O and vaccinia. Immune function of the plasmacytoma patients was similar to that of the control subjects.

Both humoral and cellular immunity in response to a newly encountered antigen, KLH, is impaired in patients with multiple myeloma.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brostoff J., Greaves M. F., Roitt I. M. IgE in lymphoid cells from pollen-stimulated cultures. Lancet. 1969 Apr 19;1(7599):803–805. doi: 10.1016/s0140-6736(69)92067-4. [DOI] [PubMed] [Google Scholar]
  2. COHEN D. M., SVIEN H. J., DAHLIN D. C. LONG-TERM SURVIVAL OF PATIENTS WITH MYELOMA OF THE VERTEBRAL COLUMN. JAMA. 1964 Mar 21;187:914–917. doi: 10.1001/jama.1964.03060250032007. [DOI] [PubMed] [Google Scholar]
  3. CONE L., UHR J. W. IMMUNOLOGICAL DEFICIENCY DISORDERS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND MULTIPLE MYELOMA. J Clin Invest. 1964 Dec;43:2241–2248. doi: 10.1172/JCI105098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Curtis J. E., Hersh E. M., Harris J. E., McBride C., Freireich E. J. The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation. Clin Exp Immunol. 1970 Apr;6(4):473–491. [PMC free article] [PubMed] [Google Scholar]
  5. FAHEY J. L., SCOGGINS R., UTZ J. P., SZWED C. F. INFECTION, ANTIBODY RESPONSE AND GAMMA GLOBULIN COMPONENTS IN MULTIPLE MYELOMA AND MACROGLOBULINEMIA. Am J Med. 1963 Nov;35:698–707. doi: 10.1016/0002-9343(63)90140-2. [DOI] [PubMed] [Google Scholar]
  6. Harris J. E., Hersh E. M., Huggins S. Human immune response to a xenogeneic nucleated cell. Transplantation. 1970 May;9(5):440–446. doi: 10.1097/00007890-197005000-00002. [DOI] [PubMed] [Google Scholar]
  7. Hersh E. M., Harris J. E. Macrophage-lymphocyte interaction in the antigen-induced blastogenic response of human peripheral blood leukocytes. J Immunol. 1968 Jun;100(6):1184–1194. [PubMed] [Google Scholar]
  8. Mitchell M. S., Wade M. E., DeConti R. C., Bertino J. R., Calabresi P. Immunosuppressive effects of cytosine arabinoside and methotrexate in man. Ann Intern Med. 1969 Mar;70(3):535–547. doi: 10.7326/0003-4819-70-3-535. [DOI] [PubMed] [Google Scholar]
  9. NOSSAL G. J., SZENBERG A., ADA G. L., AUSTIN C. M. SINGLE CELL STUDIES ON 19S ANTIBODY PRODUCTION. J Exp Med. 1964 Mar 1;119:485–502. doi: 10.1084/jem.119.3.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. PETERSON R. D., COOPER M. D., GOOD R. A. THE PATHOGENESIS OF IMMUNOLOGIC DEFICIENCY DISEASES. Am J Med. 1965 Apr;38:579–604. doi: 10.1016/0002-9343(65)90135-x. [DOI] [PubMed] [Google Scholar]
  11. STAVITSKY A. B. Micromethods for the study of proteins and antibodies. I. Procedure and general applications of hemagglutination and hemagglutination-inhibition reactions with tannic acid and protein-treated red blood cells. J Immunol. 1954 May;72(5):360–367. [PubMed] [Google Scholar]
  12. Salmon S. E., Fudenberg H. H. Abnormal nucleic acid metabolism of lymphocytes in plasma cell myeloma and macroglobulinemia. Blood. 1969 Feb;33(2):300–312. [PubMed] [Google Scholar]
  13. Swanson M. A., Schwartz R. S. Immunosuppressive therapy. The relation between clinical response and immunologic competence. N Engl J Med. 1967 Jul 27;277(4):163–170. doi: 10.1056/NEJM196707272770401. [DOI] [PubMed] [Google Scholar]
  14. ZINNEMAN H. H., HALL W. H. Recurrent pneumonia in multiple myeloma and some observations on immunologic response. Ann Intern Med. 1954 Dec;41(6):1152–1163. doi: 10.7326/0003-4819-41-6-1152. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES